Tekla Healthcare Investors Share Price Nyse
Equities
US4040521027
Closed End Funds
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 8.27M 646M | Sales 2023 | 10.29M 804M | Capitalization | 752M 58.7B |
---|---|---|---|---|---|
Net income 2022 | -194M -15.15B | Net income 2023 | 56M 4.37B | EV / Sales 2022 | 97.9 x |
Net Debt 2022 | 8.49M 663M | Net cash position 2023 | 214 16.71K | EV / Sales 2023 | 73.1 x |
P/E ratio 2022 |
-4.21
x | P/E ratio 2023 |
13.6
x | Employees | - |
Yield 2022 |
10.6% | Yield 2023 |
10.4% | Free-Float | 95.5% |
Managers | Title | Age | Since |
---|---|---|---|
Dan Omstead
PSD | President | 71 | 31/12/00 |
Chief Tech/Sci/R&D Officer | - | - | |
Jason Akus
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 31/12/06 | |
Dan Omstead
PSD | President | 71 | 31/12/00 |
Jeffrey Bailey
BRD | Director/Board Member | 62 | 31/12/19 |
1st Jan change | Capi. | |
---|---|---|
+5.34% | 12.97B | |
+14.22% | 9.75B | |
+0.95% | 5.65B | |
+31.56% | 5.23B | |
+6.24% | 5.22B | |
-4.99% | 5.04B | |
+23.73% | 4.73B | |
+2.95% | 3.91B | |
-2.97% | 3.81B |